ADMA vs REGN: Which Stock is Better?

Side-by-side comparison of ADMA Biologics Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

ADMA

ADMA Biologics Inc

REGN

Regeneron Pharmaceuticals Inc

$635.45

Key Metrics Comparison

MetricADMAREGNWinner
Market Cap$4.39B$59.10BREGN
P/E Ratio21.9013.91REGN
EPS (TTM)$N/A$N/ATie
Revenue Growth0.0%0.0%Tie
Gross Margin0.0%0.0%Tie

Analyze ADMA

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ADMA or REGN a better investment?

Comparing ADMA and REGN: ADMA Biologics Inc has a market cap of $4.39B while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ADMA and REGN?

ADMA (ADMA Biologics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ADMA or REGN?

Based on P/E ratios, REGN trades at a lower multiple (13.9x vs 21.9x).

Which is growing faster: ADMA or REGN?

Both ADMA and REGN show similar growth rates. Check our detailed analysis for quarterly trends.

Which company is more profitable: ADMA or REGN?

Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.

Which is the larger company: ADMA or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $4.39B for ADMA.

Should I buy ADMA or REGN in 2026?

Both ADMA and REGN have investment merit. ADMA trades at $N/A while REGN trades at $635.45. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ADMA and REGN stock?

Key differences: Market Cap ($4.39B vs $59.10B), P/E Ratio (21.9x vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).

Should I buy ADMA or REGN in 2026?

The choice between ADMA and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.

What is the market cap comparison between ADMA and REGN?

ADMA (ADMA Biologics Inc) has a market cap of $4.39B, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.

Popular Stock Comparisons